Markets:

Overview

News

Currencies

International

Treasuries

Tiziana Life Sciences Ltd - Common Shares (NQ:TLSA)

1.515 +0.035 (+2.36%)

Streaming Delayed Price Updated: 9:49 AM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Tiziana Life Sciences Ltd - Common Shares

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Tiziana Life Sciences Ltd (“Tiziana” or “the Company”) - Interim Results for the Six Months Ended 30 June 2022

December 27, 2022

Advancing pipeline of next generation therapeutics and diagnostics for oncology and immune diseases of high unmet need

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana to Participate in January Investor Meetings

December 16, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Announces Completion of Prerequisite Pre-Clinical Safety Study

December 15, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Ltd. Granted 180-day Extension by Nasdaq to Meet Minimum Bid Price Requirements

December 14, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Announces Date of Annual General Meeting 2022

December 06, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Announces Publication of a Peer-Reviewed Article on the Intranasal Administration of Foralumab Demonstrating Modulated Effector CD8+ T cell Function and an Induced T Cell Regulatory Response in Human Subjects

November 23, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Announces Near-Term Strategic Focus on Intranasal Foralumab for Diseases of the Central Nervous System (CNS)

November 10, 2022

-Company to host conference call via webcast at 10 am ET-

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences to Host Investor Call

November 04, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Announces Purchase of Common Shares by Executive Chairman

November 03, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Completes Enrollment of the First Patient Cohort for its Intermediate-Size Patient Population Expanded Access Program to Evaluate Foralumab in Non-Active Secondary Multiple Sclerosis Patients

November 02, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Starts Enrollment of the First Patient Cohort in its Intermediate Size Patient Population Expanded Access Program to Evaluate Foralumab in Non-Active Secondary Multiple Sclerosis Patients

October 26, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Ltd Invites You to Join Us at The ThinkEquity Conference

October 19, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗

October 12, 2022

It's time for another dive into the biggest pre-market stock movers as we check out what's behind shares moving on Wednesday!

Via InvestorPlace

Tiziana Life Sciences Plans to Submit IND for Phase 1 Trial of Intranasal Foralumab in Alzheimer's Disease Patients

October 12, 2022

Company continues to advance foralumab in CNS-related inflammatory diseases

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

DWAC Stock Falls Ahead Of Trump Deadline Vote On Monday ↗

October 07, 2022

DWAC is losing institutional investment dollars and Trump could find himself back on Twitter soon.

Via Investor's Business Daily

Tiziana Life Sciences Announces Purchase of Common Shares by Chief Medical Officer

September 29, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

Tiziana Life Sciences Announces Presentations on Intranasal Foralumab at the “Preserving the Brain” Scientific Conference and Exhibit at the Fondazione Prada in Milan

September 28, 2022

From Tiziana Life Sciences Ltd.

Via GlobeNewswire

US Inflation Reduction Act Could Supercharge Canada's Cobalt-Related Sectors ↗

September 23, 2022

The rapidly emerging battery metals market just gained a major driver that will last for decades. That driver is the US Inflation Reduction Act (IRA), which was passed on August 7, 2022.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

September 22, 2022

It's time for an overview of the biggest pre-market stock movers for Thursday and all the news behind this morning's movement.

Via InvestorPlace

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket ↗

September 22, 2022

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem...

Via Benzinga

Why KnowBe4 Shares Jumped Over 28%; Here Are 79 Biggest Movers From Yesterday ↗

September 20, 2022

Gainers Ventoux CCM Acquisition Corp. (NASDAQ: VTAQ) shares jumped 54.6% to settle at $7.05 on Monday.

Via Benzinga

Why Virios Therapeutics Is Trading Lower By Over 71%, Here Are 55 Stocks Moving In Monday's Mid-Day Session ↗

September 19, 2022

Gainers MicroCloud Hologram Inc. (NASDAQ: HOLO) shares jumped 134.6% to $19.74.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday ↗

August 18, 2022

It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!

Via InvestorPlace

This Healthcare Stock Is Trading Lower By 29%: Here Are 29 Stocks Moving Premarket ↗

August 18, 2022

Gainers

Via Benzinga

This Healthcare Stock is Surging By Over 21%: Here's 24 Biggest Movers In Tuesday's Pre-Market ↗

July 12, 2022

Gainers Versus Systems Inc. (NASDAQ: VS) rose 66% to $0.7802 in pre-market trading. Versus Systems, last month, received NASDAQ notification regarding minimum bid price deficiency.

Via Benzinga

Tiziana Life Sciences Shares Jump After Multiple Sclerosis Data From Second Patient ↗

June 08, 2022

Tiziana Life Sciences (NASDAQ: TLSA) reported clinical results from the second patient with Secondary Progressive Multiple Sclerosis (SPMS) in the ongoing study as part of an expanded access program.

Via Benzinga

83 Biggest Movers From Yesterday ↗

June 09, 2022

Gainers Symbotic Inc. (NASDAQ: SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly...

Via Benzinga

50 Stocks Moving In Wednesday's Mid-Day Session ↗

June 08, 2022

Gainers HeartCore Enterprises, Inc. (NASDAQ: HTCR) shares gained 81% to $1.8503 after the company authorized a $3.5 million buyback.

Via Benzinga

LTUM Stock Alert: Why Is Lithium Corporation Stock Up Today? ↗

April 13, 2022

It turns out that Lithium Corporation is not being acquired by Tesla. Here's why LTUM stock will likely fall as quickly as it rose today.

Via InvestorPlace

58 Biggest Movers From Yesterday ↗

May 24, 2022

Gainers Catalyst Biosciences, Inc. (NASDAQ: CBIO) gained 234.2% to close at $1.27 after the company announced it sold its complement portfolio for $60 million.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.